Page last updated: 2024-08-18

pyrroles and Pain

pyrroles has been researched along with Pain in 134 studies

Research

Studies (134)

TimeframeStudies, this research(%)All Research%
pre-199039 (29.10)18.7374
1990's11 (8.21)18.2507
2000's37 (27.61)29.6817
2010's35 (26.12)24.3611
2020's12 (8.96)2.80

Authors

AuthorsStudies
Agner, T; Bauer, A; Ehst, B; Korn, S; Resen, K; Schliemann, S; Shi, VY; Thyssen, JP; Tillmann, S; Worm, M1
Cappelleri, JC; Dina, O; Fallon, L; Fleishaker, D; Magrey, M; Navarro-Compán, V; Strand, V; Van den Bosch, F; Wang, C; Wang, L; Wei, JC; Wu, J1
Damron, TA1
Abdalla, AN; Abourehab, MAS; Ahmed, M; Aslam, A; Attalah, KM; ElSawy, NA; Gouda, AM1
Ailani, J; Dodick, DW; Finnegan, M; Lipton, RB; Lu, K; Szegedi, A; Trugman, JM1
Chen, HY; Chen, J; Diamantidis, CJ; Doerfler, RM; Fink, JC; Rahman, M; Ricardo, AC; Sondheimer, J; Strauss, L; Wagner, LA; Weir, MR; Xie, D; Zhan, M1
Case, M; Doty, EG; Dowsett, SA; Krege, JH; Pohl, G; Tepper, SJ1
Alten, R; Diehl, A; Germino, R; Kaine, J; Murray, CW; Shi, H; Strand, V; Wallenstein, G1
Blumenfeld, AM; Dodick, DW; Goadsby, PJ; Jakate, A; Kalidas, K; Lipton, RB; Liu, C; M Adams, A; Szegedi, A; Trugman, JM1
Croop, R; L'Italien, GJ; Stock, DA1
Arantes, ALF; Cazuza, RA; Leite-Panissi, CRA; Pol, O1
Blumenfeld, AM; Hutchinson, S; Lipton, RB; Lu, K; Severt, L; Silberstein, SD; Yu, SY1
Fukuda, I; Hasegawa, M; Higashino, K; Hinata, M; Horita, N; Ikeda, M; Imai, M; Imai, S; Kanemasa, T; Minami, M; Morioka, Y; Morita, A; Sakaguchi, G; Sanaki, T; Soga, M; Tsuchida, J; Yamamoto, M; Yamane, S; Yoshioka, T1
Alfonso, S; Battilocchio, C; Biava, M; Consalvi, S; Di Cesare Mannelli, L; Di Francesco, L; Ghelardini, C; Giordani, A; Pace, S; Patrignani, P; Poce, G; Porretta, GC; Rossi, A; Sautebin, L; Schenone, S1
Meirer, K; Proschak, E; Steinhilber, D1
Brunelle, S; Cappiello, M; Gilabert, M; Gravis, G; Provansal, M; Salem, N; Tarpin, C; Thomassin, J; Walz, Y1
Amato, AA; Puig, A; Scripko, PD1
Aoki, Y; Mizoguchi, H; Sakurada, S; Sakurada, T; Takeda, K; Watanabe, C1
Abogadie, FC; Bunnett, NW; Darby, B; Grace, MS; Lieu, T; McIntyre, P; Veldhuis, N1
Brenner, D; Chen, Y; Fang, Q; Gereau, RW; Kanju, P; Lee, SH; Lee, W; Liedtke, W; Moore, C; Parekh, PK; Wang, F1
Aydınok, Y; Balkan, C; Karadaş, N; Kavaklı, K; Önder Siviş, Z; Yılmaz Karapınar, D1
Burton, EA; Chartier, S; Habets, G; Jimenez-Andrade, JM; Lin, PS; Mantyh, PW; Thompson, ML; Tsai, J; West, BL1
Abraham, S; Hayes, ES; Pugsley, MK; Saint, DA; Walker, MJ1
Alcocer-Gómez, E; Apetoh, L; Battino, M; Bullón, P; Carrión, AM; Cordero, MD; Culic, O; Garrido-Maraver, J; Ghiringhelli, F; Marín-Aguilar, F; Román-Malo, L; Ruiz-Cabello, J; Ryffel, B; Sánchez-Alcazar, JA1
Deevska, G; Kline, RH; Ma, F; Nikolova-Karakashian, M; Westlund, KN; Zhang, LP1
Daanen, JF; DeGoey, DA; El-Kouhen, OF; Fricano, MM; Frost, JM; Ghoreishi-Haack, N; Gum, RJ; Hsieh, GC; Kort, ME; Lundgaard, GL; Matulenko, MA; Neelands, T; Pai, M; Shi, L; Zhan, C; Zhang, XF1
Ahmad, A; Choudhary, D; Hasan, SM; Husain, A; Khan, SA; Khokra, SL1
Abdallah, AO; Arnaoutakis, K; Mahmoud, F; Makhoul, I1
Amano, T; Hara, T; Ide, S; Kaneda, K; Kaneko, T; Minami, M; Ohno, A; Takahashi, D; Yoshioka, M1
Augustin, M; Buonanno, M; de la Cruz, C; Feldman, SR; Gooderham, M; Kaur, M; Lan, S; Mallbris, L; Mamolo, C; Tatulych, S; Thaçi, D; Valdez, H1
Andrews, M; Bagal, SK; Bilsland, J; Brown, D; Bungay, PJ; Cole, S; Gibson, KR; Jones, R; Morao, I; Nedderman, A; Omoto, K; Robinson, C; Ryckmans, T; Skerratt, SE; Skinner, K; Stupple, P; Waldron, G1
Adwanikar, H; Fu, Y; Han, J; Ishola, T; Neugebauer, V; Ramsey, C; Scerbo, M1
Abou-Raya, A; Abou-Raya, S; Helmii, M1
Clohisy, DR; Dudek, AZ; Ericson, ME; Gallus, NJ; Jasinski, P; Terai, K; Zwolak, P1
Elsais, A; Kerty, E; Lund, C1
Anzellotti, P; Anzini, M; Biava, M; Botta, M; Cirilli, R; Ferretti, R; Forli, S; Gallinella, B; Ghelardini, C; Giordani, A; La Torre, F; Makovec, F; Manetti, F; Norcini, M; Patrignani, P; Pergola, C; Poce, G; Porretta, GC; Rossi, A; Sautebin, L; Supino, S1
Alon, US; Haney, CJ; Srivastava, T1
Beuselinck, B; Pans, S; Schöffski, P; Wolter, P1
Bloom, BJ; Breedveld, FC; Burgos-Vargas, R; Coombs, JH; Fletcher, MP; Gruben, D; Kremer, JM; Wilkinson, B; Zerbini, CA; Zwillich, SH1
Barreiro, EJ; Fraga, CA; Mendes, TC; Nascimento-Junior, NM; Raimundo, JM; Sudo, RT; Zapata-Sudo, G1
Grover, RK; Rao, PN1
Blesa, JM; Pulido, EG1
Cui, JH; Kim, WM; Yoon, MH1
Cummons, T; Harrison, JE; Hummel, M; Kennedy, JD; Lu, P; Mark, L; Whiteside, GT1
Ahire, YS; Dandawate, PR; Gandhi, SP; Ghaisas, MM; Zawar, SA1
Abram, F; Dorais, M; Martel-Pelletier, J; Pelletier, JP; Raynauld, JP; Wildi, LM1
Dybała, M; Filipek, B; Jastrzębska-Więsek, M; Kalicki, P; Karczmarzyk, Z; Malinka, W; Redzicka, A; Urbańczyk-Lipkowska, Z1
Garcia, GG; Miranda, HF; Noriega, V; Olavarría, L; Prieto, JC; Sierralta, F; Zepeda, RJ1
Baiuomy, AR; Elmegeed, GA; Eskander, EF; Mohareb, RM; William, MG1
Bregman, H; Buchanan, JL; Chakka, N; Dimauro, EF; Du, B; Feric, E; Ligutti, J; Liu, D; McDermott, JS; McDonough, SI; Nguyen, HN; Zou, A1
Dai, Y; Kobayashi, K; Kogure, Y; Noguchi, K; Wan, Y; Wang, S; Yamanaka, H; Zhang, W; Zhu, W1
Bruckert, E; Dallongeville, J; Rosenbaum, D; Sabouret, P1
Bilsland, J; Cao, L; Chambers, SM; Lee, G; Mica, Y; Niu, L; Qi, Y; Shi, SH; Stevens, E; Studer, L; Whiting, P; Zhang, XJ1
Gropp, C1
Chen, J; Chi, ZQ; Long, YQ; Mou, QY; Zhou, DH; Zhu, YC1
Bannykh, S; England, JD; Gray, NL; Haas, RH; Hathaway, S; Kimura, BJ; Phillips, PS; Vladutiu, GD1
Backonja, MM; Dotson, RM; Dworkin, RH; Galer, BS; Katz, NP; Meisner, PD; Quessy, SN; Rauck, RL; Rowbotham, MC; Wallace, MS1
Bendahan, D; Bernard, V; Cozzone, PJ; Figarella-Branger, D; Guis, S; Kozak-Ribbens, G; Lando, A; Mattei, JP; Pellissier, JF; Treffouret, S1
Dewey, WL; Elzey, MJ; Javed, RR; Smith, FL1
Blackburn-Munro, G; Bomholt, SF; Erichsen, HK1
Aceto, MD; Breeden, S; Husbands, SM; Ko, MC; Lewis, JW; Neilan, CL; Traynor, JR; Woods, JH1
Gibson, E; Luo, D; Newman, C; Szarek, M; Tsai, J1
Atkinson, S; Brown, SH; Chessell, IP; Chowdhury, A; Clayton, NM; Coleman, T; Giblin, GM; Gleave, RJ; Hall, A; Hammond, B; Healy, MP; Johnson, MR; Michel, AD; Naylor, A; Novelli, R; Spalding, DJ; Tang, SP1
Dewey, WL; Gabra, BH; Javed, RR; Smith, FL; Smith, PA1
Brown, SH; Chessell, IP; Chowdhury, A; Clayton, NM; Coleman, T; Giblin, GM; Hall, A; Hammond, B; Healy, MP; Johnson, MR; Metcalf, A; Michel, AD; Naylor, A; Novelli, R; Spalding, DJ; Sweeting, J1
Brown, SH; Chessell, IP; Chowdhury, A; Clayton, NM; Coleman, T; Giblin, GM; Hall, A; Hammond, B; Healy, MP; Johnson, MR; Metcalf, A; Michel, AD; Naylor, A; Novelli, R; Spalding, DJ; Sweeting, J; Winyard, L1
Hiatt, WH; Linnebur, SA1
Dande, A; Holford, TR; Kocherla, M; Ruaño, G; Seip, RL; Smith, A; Sorokin, A; Thompson, PD; Windemuth, A; Wu, AH1
Di Lorenzo, L1
Rosenberg, L; Uretsky, S1
Inoue, S; Kawara, A; Kimura, T; Kumakura, S; Murakami, Y; Nakao, A; Suzuki, K; Ushiyama, S; Yamada, T1
Bertorelli, R; Burnett, DA; Domalski, M; Fredduzzi, S; Greenlee, WJ; Li, C; Lozza, G; Reggiani, A; Veltri, A; Wu, WL1
Atkins, JN; Belani, CP; Brahmer, JR; Chao, RC; Gillenwater, HH; Govindan, R; Novello, S; Pallares, C; Rosell, R; Sanchez, JM; Scagliotti, GV; Selaru, P; Socinski, MA; Tye, L1
Bilbie, CL; Clarkson, PM; Gadarla, M; Kearns, AK; O'Fallon, KS; Sewright, KA; Thompson, PD; White, CM1
Chen, J; Chi, ZQ; Ju, YW; Li, QL; Liu, JG; Long, YQ; Tao, YM; Xu, XJ; Zhang, CF1
Jefferson, WL; Steele, CE1
Lacher, JW; Miller, FC; Schorr, WJ1
Schady, W; Torebjörk, HE1
Imazu, C; Ishii, K; Kadokawa, T; Nakamura, H; Shimizu, M; Yokoyama, Y1
Creasy, GW; Kousen, M; Walker, WR1
Lisker, WH1
Kiani, R; Kushner, M1
Mosley, C; Warren, SE1
Gever, LN1
Braun, H1
Cenarruzabeitia, E; Fontan, JL; Lasheras, B1
Maloney, PJ; Rooks, WH; Schuler, ME; Tomolonis, AJ; Wallach, MB1
Stambaugh, JE; Tejada, F; Trudnowski, RJ1
Mayer, TG; Ruoff, GE1
Davies, J; Dixon, AS; Steele, CE1
Bach-Andersen, R; Persson, B; Telhag, H1
Avery, GS; Brogden, RN; Carmine, AA; Heel, RC; Morley, PA; Speight, TM1
van Thiel, D2
Gorder, JW1
Smith, VT1
Theron, F1
Handrich, L1
Nakamura, H; Shimizu, M1
Barth, WF; Ruppert, GB1
Baeyens, JM; Barrios, M; Del Pozo, E; Ocaña, M1
Carruette, A; Garret, C; Moussaoui, S1
Diop, L; Junien, JL; Langlois, A; Pascaud, X; Rivière, PJ1
Baeyens, JM; Barrios, M; Ocaña, M1
Angel, F; Chevalier, E; Dahl, SG; Friese, N; Junien, JL; Pascaud, X; Riviere, PJ1
Gjerstad, J; Hole, K; Tjølsen, A1
Berridge, CW; Dikkes, P; Dunn, AJ; Majzoub, JA; Miczek, KA; Muglia, LJ; Swiergiel, AH; Weninger, SC1
Kamei, J; Ohsawa, M1
Kleinrok, Z; Malinka, W; Rajtar, G; Rejdak, K; Rejdak, R; Sieklucka-Dziuba, M1
Aoki, T; Mizoguchi, H; Narita, M; Ohsawa, M; Suzuki, T; Tseng, LF1
Lupattelli, G; Palumbo, B; Sinzinger, H1
Goto, F; Ishizaki, K; Obata, H; Sasaki, M1
Bagheri, H; Faixo, Y; Montastruc, JL; Sulem, P1
Bettelini, L; Corsi, M; Fasdelli, N; Maraia, G; Quartaroli, M1
Heidrich, G; Houde, RW; Kaiko, RF; Rogers, A; Wallenstein, SL1
Bauer, P; Ehn, I; Schreiber, E; Stacher, G1
Cowan, A; Wheeler-Aceto, H2
Artico, M; Giorgi, R; Palumbo, G; Pantaleoni, GC; Silvestri, R; Stefancich, G1
Cowan, A; Ianone, M; Porreca, F; Wheeler, H1
Hill, RG; Hughes, J; Johnson, MA; Leighton, GE; Meecham, KG1
Conrad, KA; Fagan, TC; Mackie, MJ; Mayshar, PV1
Barden, TP; Bloomfield, SS; Cissell, GB; Mitchell, J; Nelson, ED; Peters, NM1
Amadio, P; Cummings, DM1
Ackrell, J; Cheung, P; Cook, J; Cooper, GF; Gallegra, P; Halpern, O; Kluge, AF; Koehler, R; Muchowski, JM; Unger, SH1
Brooks, PM; Lee, P; Sturrock, RD; Watkins, CF1
Frigerio, G1
Azzollini, F; Lodola, E1
Martinetti, L; Monafo, V1
Gentz, J; Johansson, S; Lindblad, B; Lindstedt, S; Zetterström, R1

Reviews

5 review(s) available for pyrroles and Pain

ArticleYear
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
    Science & sports, 2023, Apr-04

    Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide

2023
Inhibitors of the arachidonic acid cascade: interfering with multiple pathways.
    Basic & clinical pharmacology & toxicology, 2014, Volume: 114, Issue:1

    Topics: Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Cyclooxygenase 2 Inhibitors; Cytochrome P-450 Enzyme System; Epoxide Hydrolases; Humans; Inflammation; Lipoxygenase Inhibitors; Pain; Pyrroles

2014
Hypertension and Life-Threatening Bleeding in Children with Relapsed Acute Myeloblastic Leukemia Treated with FLT3 Inhibitors.
    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2015, Volume: 32, Issue:3

    Topics: Acidosis; Acute Kidney Injury; Adenine Nucleotides; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Child; Child, Preschool; Clofarabine; Cytarabine; Fatal Outcome; Female; fms-Like Tyrosine Kinase 3; Hemorrhage; Humans; Hypertension; Indoles; Leukemia, Myeloid, Acute; Male; Neoplasm Proteins; Niacinamide; Pain; Pancytopenia; Phenylurea Compounds; Protease Inhibitors; Pyrroles; Salvage Therapy; Sepsis; Sorafenib; Sunitinib

2015
Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients.
    The American journal of cardiology, 2006, Jan-01, Volume: 97, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Albuminuria; Aspartate Aminotransferases; Atorvastatin; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Utilization; Female; Hematuria; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscular Diseases; Pain; Pyrroles; Retrospective Studies

2006
Zomepirac: a review of its pharmacological properties and analgesic efficacy.
    Drugs, 1982, Volume: 23, Issue:4

    Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Interactions; Humans; Kinetics; Pain; Pyrroles; Substance-Related Disorders; Tolmetin

1982

Trials

32 trial(s) available for pyrroles and Pain

ArticleYear
The pan-JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16-week randomized phase IIb trial.
    The British journal of dermatology, 2022, Volume: 187, Issue:1

    Topics: Adult; Dermatitis, Atopic; Double-Blind Method; Eczema; Emollients; Humans; Immunoglobulin A; Janus Kinase Inhibitors; Pain; Pruritus; Pyrroles; Severity of Illness Index; Treatment Outcome

2022
Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trial.
    RMD open, 2022, Volume: 8, Issue:2

    Topics: Adult; Antirheumatic Agents; Fatigue; Humans; Pain; Piperidines; Pyrimidines; Pyrroles; Quality of Life; Spondylitis, Ankylosing; Treatment Outcome

2022
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
    Science & sports, 2023, Apr-04

    Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide

2023
Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial.
    JAMA, 2019, 11-19, Volume: 322, Issue:19

    Topics: Adult; Aged; Analgesics; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Pain; Pain Management; Pyridines; Pyrroles; Young Adult

2019
Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib.
    Arthritis research & therapy, 2020, 10-15, Volume: 22, Issue:1

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Fatigue; Humans; Pain; Piperidines; Pyrimidines; Pyrroles; Treatment Outcome

2020
Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implications.
    Cephalalgia : an international journal of headache, 2021, Volume: 41, Issue:5

    Topics: Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain; Pyridines; Pyrroles; Treatment Outcome

2021
Safety and efficacy of ubrogepant in participants with major cardiovascular risk factors in two single-attack phase 3 randomized trials: ACHIEVE I and II.
    Cephalalgia : an international journal of headache, 2021, Volume: 41, Issue:9

    Topics: Adult; Calcitonin Gene-Related Peptide Receptor Antagonists; Cardiovascular Diseases; Double-Blind Method; Female; Heart Disease Risk Factors; Humans; Male; Migraine Disorders; Pain; Pyridines; Pyrroles; Risk Factors; Treatment Outcome

2021
Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis.
    Journal of the American Academy of Dermatology, 2016, Volume: 75, Issue:6

    Topics: Adult; Female; Humans; Male; Middle Aged; Pain; Patient Satisfaction; Piperidines; Protein Kinase Inhibitors; Pruritus; Psoriasis; Pyrimidines; Pyrroles; Quality of Life; Severity of Illness Index

2016
Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    The Journal of rheumatology, 2008, Volume: 35, Issue:9

    Topics: Atorvastatin; Double-Blind Method; Female; Fingers; Health Status; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pain; Pain Measurement; Pyrroles; Raynaud Disease; Scleroderma, Systemic; Severity of Illness Index; Skin Ulcer; Surveys and Questionnaires; Treatment Outcome

2008
Atorvastatin may have no effect on acute phase reaction in children after intravenous bisphosphonate infusion.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2009, Volume: 24, Issue:2

    Topics: Acetaminophen; Acute-Phase Reaction; Anticholesteremic Agents; Atorvastatin; Bone Density Conservation Agents; C-Reactive Protein; Child; Diphosphonates; Female; Heptanoic Acids; Humans; Infusions, Intravenous; Male; Oxycodone; Pain; Placebos; Pyrroles

2009
Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial.
    Annals of the rheumatic diseases, 2010, Volume: 69, Issue:2

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Epidemiologic Methods; Female; Humans; Janus Kinase 3; Male; Middle Aged; Pain; Pain Measurement; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recovery of Function; Treatment Outcome

2010
Relationship between bone marrow lesions, cartilage loss and pain in knee osteoarthritis: results from a randomised controlled clinical trial using MRI.
    Annals of the rheumatic diseases, 2010, Volume: 69, Issue:12

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow Diseases; Cartilage, Articular; Cyclooxygenase Inhibitors; Epidemiologic Methods; Female; Humans; Knee Joint; Magnetic Resonance Imaging; Male; Middle Aged; Naproxen; Osteoarthritis, Knee; Pain; Pain Measurement; Pyrroles

2010
Statin-associated myopathy with normal creatine kinase levels.
    Annals of internal medicine, 2002, Oct-01, Volume: 137, Issue:7

    Topics: Aged; Anticholesteremic Agents; Atorvastatin; Biopsy; Creatine Kinase; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Muscular Diseases; Pain; Pyrroles; Simvastatin

2002
A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain.
    Neurology, 2002, Dec-10, Volume: 59, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Glycine; Glycine Agents; Hot Temperature; Humans; Indoles; Male; Middle Aged; Pain; Pain Measurement; Patient Satisfaction; Peripheral Nervous System Diseases; Pyrroles; Sensory Thresholds; Treatment Outcome

2002
Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Feb-01, Volume: 26, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Cause of Death; Cisplatin; Disease Progression; Drug Administration Schedule; Fatigue; Female; Humans; Indoles; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neoplasm Staging; Pain; Protein-Tyrosine Kinases; Pyrroles; Remission Induction; Stomatitis; Sunitinib; Treatment Outcome

2008
The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg.
    Atherosclerosis, 2008, Volume: 200, Issue:1

    Topics: Adult; Anticholesteremic Agents; Atorvastatin; Creatine Kinase; Dose-Response Relationship, Drug; Exercise; Exercise Test; Heptanoic Acids; Humans; Male; Middle Aged; Muscle, Skeletal; Pain; Pyrroles

2008
A multi-centre study of zomepirac in painful conditions: an analysis of clinical data for 15,484 patients.
    Current medical research and opinion, 1983, Volume: 8, Issue:6

    Topics: Adolescent; Adult; Aged; Back Pain; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Osteoarthritis; Pain; Pyrroles; Sleep; Tolmetin

1983
Double-blind comparisons of zomepirac and oxycodone with APC in cancer pain.
    Journal of clinical pharmacology, 1980, Volume: 20, Issue:4

    Topics: Adult; Analgesics; Aspirin; Caffeine; Clinical Trials as Topic; Codeine; Double-Blind Method; Drug Combinations; Female; Humans; Male; Neoplasms; Oxycodone; Pain; Phenacetin; Pyrroles; Tolmetin

1980
Clinical evaluation of zomepirac in the treatment of acute orthopedic pain.
    Journal of clinical pharmacology, 1980, Volume: 20, Issue:4

    Topics: Adult; Analgesics; Aspirin; Caffeine; Clinical Trials as Topic; Codeine; Double-Blind Method; Drug Combinations; Female; Humans; Male; Pain; Phenacetin; Pyrroles; Tolmetin; Wounds and Injuries

1980
Tolmetin sodium and indomethacin in the treatment of osteoarthrosis of the hip: a double-blind crossover study.
    Current medical research and opinion, 1980, Volume: 7, Issue:2

    Topics: Activities of Daily Living; Aged; Clinical Trials as Topic; Double-Blind Method; Hip; Humans; Indomethacin; Middle Aged; Osteoarthritis; Pain; Pyrroles; Tolmetin

1980
Zomepirac sodium -- a new oral analgesic.
    The Medical letter on drugs and therapeutics, 1981, Jan-09, Volume: 23, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Codeine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Pain; Placebos; Pyrroles; Tolmetin

1981
A double-blind comparative evaluation of tolmetin versus naproxen in osteoarthritis.
    Current medical research and opinion, 1981, Volume: 7, Issue:6

    Topics: Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Naproxen; Osteoarthritis; Pain; Pyrroles; Tolmetin

1981
[An analgesic opens new therapeutic possibilities].
    Therapie der Gegenwart, 1982, Volume: 121, Issue:7

    Topics: Analgesics; Clinical Trials as Topic; Double-Blind Method; Humans; Pain; Pyrroles; Tolmetin

1982
The intra-uterine contraceptive device -- an attempt to prevent pain and expulsion with zomepirac sodium.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1982, Jun-12, Volume: 61, Issue:24

    Topics: Adolescent; Adult; Analgesics; Double-Blind Method; Female; Follow-Up Studies; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Pain; Pyrroles; Tolmetin

1982
[Comparison of the therapeutic efficacy and tolerability of acemetacin and tolmetin (author's transl)].
    Arzneimittel-Forschung, 1980, Volume: 30, Issue:8A

    Topics: Adult; Aged; Anti-Inflammatory Agents; Double-Blind Method; Female; Humans; In Vitro Techniques; Indoleacetic Acids; Indomethacin; Inflammation; Male; Middle Aged; Pain; Pyrroles; Tolmetin

1980
Effects of tolmetin, paracetamol, and of two combinations of tolmetin and paracetamol as compared to placebo on experimentally induced pain. A double blind study.
    International journal of clinical pharmacology and biopharmacy, 1979, Volume: 17, Issue:6

    Topics: Acetaminophen; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Electric Stimulation; Female; Hot Temperature; Humans; Male; Pain; Placebos; Pyrroles; Tolmetin

1979
Effects of ketorolac tromethamine on hemostasis in volunteers.
    Clinical pharmacology and therapeutics, 1988, Volume: 43, Issue:5

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Combinations; Ecchymosis; Hemostasis; Humans; Injections, Intramuscular; Ketorolac Tromethamine; Middle Aged; Pain; Pyrroles; Tolmetin; Tromethamine

1988
Anirolac vs. naproxen for postpartum uterine pain.
    Clinical pharmacology and therapeutics, 1987, Volume: 42, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Double-Blind Method; Drug Evaluation; Female; Humans; Naproxen; Pain; Postpartum Period; Pregnancy; Pyrroles; Random Allocation

1987
The effect of tolmetin on the chronic pain and decreased functional capacity associated with degenerative joint disease.
    Journal of clinical pharmacology, 1985, Volume: 25, Issue:2

    Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Osteoarthritis; Pain; Pyrroles; Random Allocation; Tolmetin

1985
[Viminol in the treatment of pain. Double-blind, controlled, multicentric trial].
    Minerva medica, 1974, Feb-17, Volume: 65, Issue:12

    Topics: Aminopyrine; Analgesics; Aspirin; Benzoates; Benzyl Compounds; Dextropropoxyphene; Drug Evaluation; Drug Tolerance; Ethanolamines; Female; Humans; Male; Morphine; Nausea; Pain; Pentazocine; Phenylbutazone; Pyrroles; Sleep Wake Disorders; Vertigo

1974
Diviminol (Z 424): a pilot study for prolonged clinical use.
    Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology, 1971, Volume: 4, Issue:3

    Topics: Adult; Aged; Amines; Amino Alcohols; Analgesics; Benzyl Compounds; Blood Pressure; Body Temperature; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Nalorphine; Pain; Pulse; Pyrroles; Respiration; Substance Withdrawal Syndrome

1971
A clinical study of diviminol on prolonged administration.
    Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology, 1971, Volume: 4, Issue:3

    Topics: Adult; Aged; Amines; Amino Alcohols; Analgesics; Benzyl Compounds; Blood Pressure; Clinical Trials as Topic; Drug Tolerance; Female; Humans; Male; Middle Aged; Pain; Pulse; Pyrroles; Respiration; Substance Withdrawal Syndrome

1971

Other Studies

98 other study(ies) available for pyrroles and Pain

ArticleYear
CORR Insights®: Pexidartinib Provides Modest Pain Relief in Patients With Tenosynovial Giant Cell Tumor: Results From ENLIVEN.
    Clinical orthopaedics and related research, 2023, 01-01, Volume: 481, Issue:1

    Topics: Aminopyridines; Giant Cell Tumor of Tendon Sheath; Humans; Pain; Pyrroles

2023
Ethyl benzoate bearing pyrrolizine/indolizine moieties: Design, synthesis and biological evaluation of anti-inflammatory and cytotoxic activities.
    Bioorganic chemistry, 2020, Volume: 94

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Benzoates; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Edema; Humans; Indolizines; Inflammation; Molecular Structure; Pain; Pyrroles; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship

2020
Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2020, Volume: 76, Issue:2

    Topics: Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Black or African American; Cohort Studies; Disease Progression; Female; Glomerular Filtration Rate; Hospitalization; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mortality; Pain; Proportional Hazards Models; Prospective Studies; Pyrimidines; Pyrroles; Quality of Life; Renal Insufficiency, Chronic; Renal Replacement Therapy; White People; Young Adult

2020
Pain Freedom at 2 to 8 Hours With Lasmiditan: A Comparison With Rimegepant and Ubrogepant.
    Headache, 2020, Volume: 60, Issue:8

    Topics: Benzamides; Freedom; Humans; Pain; Piperidines; Pyridines; Pyrroles

2020
Pain Freedom at 2-8 Hours With Lasmiditan: A Comparison With Rimegepant and Ubrogepant: A Response.
    Headache, 2020, Volume: 60, Issue:10

    Topics: Benzamides; Freedom; Humans; Pain; Piperidines; Pyridines; Pyrroles

2020
HO-CO pathway activation may be associated with hippocampal μ and δ opioid receptors in inhibiting inflammatory pain aversiveness and nociception in WT but not NOS2-KO mice.
    Brain research bulletin, 2021, Volume: 169

    Topics: Animals; Avoidance Learning; Carbon Monoxide; Heme Oxygenase (Decyclizing); Hippocampus; Male; Mice; Mice, Knockout; Nociception; Organometallic Compounds; Pain; Pain Measurement; Pyrazines; Pyrroles; Receptors, Opioid, delta; Receptors, Opioid, mu; Signal Transduction

2021
Sensitization of transient receptor potential vanilloid 4 and increasing its endogenous ligand 5,6-epoxyeicosatrienoic acid in rats with monoiodoacetate-induced osteoarthritis.
    Pain, 2018, Volume: 159, Issue:5

    Topics: Animals; Arthritis, Experimental; Disease Models, Animal; Ganglia, Spinal; Hand Strength; Iodoacetic Acid; Leucine; Male; Morpholines; Neurons; Osteoarthritis; Pain; Pain Measurement; Phosphorylation; Pyrroles; Rats; Rats, Sprague-Dawley; Sulfonamides; TRPV Cation Channels

2018
A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity.
    Bioorganic & medicinal chemistry, 2013, Jul-01, Volume: 21, Issue:13

    Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cyclooxygenase 2 Inhibitors; Male; Mice; Pain; Pyrroles; Structure-Activity Relationship

2013
Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma.
    British journal of cancer, 2013, Oct-01, Volume: 109, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Oral Hygiene; Pain; Periodontal Index; Pyrroles; Sunitinib; Surveys and Questionnaires; Tooth Migration; Treatment Outcome

2013
Mystery case: a 63-year-old man with progressive proximal pain and weakness.
    Neurology, 2014, Jan-28, Volume: 82, Issue:4

    Topics: Atorvastatin; Blood Sedimentation; C-Reactive Protein; Creatine Kinase; Diabetes Mellitus, Type 2; Disease Progression; Electromyography; Fatigue; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscle Weakness; Neuromuscular Junction Diseases; Pain; Pyrroles; Shoulder Pain; Tomography, X-Ray Computed

2014
Potential involvement of μ-opioid receptor dysregulation on the reduced antinociception of morphine in the inflammatory pain state in mice.
    Journal of pharmacological sciences, 2014, Volume: 124, Issue:2

    Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Freund's Adjuvant; Ganglia, Spinal; Hyperalgesia; Indoles; Inflammation; Injections, Subcutaneous; Male; Mice; Mice, Inbred Strains; Morphine; Pain; Phosphorylation; Protein Kinase C-alpha; Pyrroles; Receptors, Opioid, mu; Spinal Cord

2014
The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivo.
    British journal of pharmacology, 2014, Volume: 171, Issue:16

    Topics: Animals; HEK293 Cells; Humans; Hyperalgesia; Leucine; Male; Mice, Inbred C57BL; Morpholines; Oligopeptides; Pain; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Receptor, PAR-2; Sulfonamides; TRPV Cation Channels; Trypsin

2014
TRPV4 is necessary for trigeminal irritant pain and functions as a cellular formalin receptor.
    Pain, 2014, Volume: 155, Issue:12

    Topics: Animals; Butadienes; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Fixatives; Formaldehyde; Keratinocytes; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Transgenic; Morpholines; Neurons; Nitriles; Pain; Pyrroles; Trigeminal Ganglion; TRPV Cation Channels; Ubiquitin Thiolesterase; Vibrissae

2014
Targeting cells of the myeloid lineage attenuates pain and disease progression in a prostate model of bone cancer.
    Pain, 2015, Volume: 156, Issue:9

    Topics: Aminopyridines; Analgesics; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Dogs; Formaldehyde; Male; Mice; Mice, Nude; Neoplasm Transplantation; Pain; Pain Measurement; Prostatic Neoplasms; Protein Kinases; Pyrroles; Rats; Rats, Sprague-Dawley

2015
An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.
    European journal of pharmacology, 2015, Aug-15, Volume: 761

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Binding, Competitive; Cardiac Pacing, Artificial; Cerebellum; Coronary Occlusion; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Guinea Pigs; Heart Conduction System; Heart Rate; Heart Ventricles; Isolated Heart Preparation; Ligands; Male; Mice, Inbred BALB C; Myocardial Contraction; Pain; Pain Threshold; Potassium Channel Blockers; Potassium Channels; Protein Binding; Pyrroles; Radioligand Assay; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Sodium Channel Blockers; Sodium Channels; Thiophenes; Ventricular Function, Left; Ventricular Pressure

2015
AMPK Phosphorylation Modulates Pain by Activation of NLRP3 Inflammasome.
    Antioxidants & redox signaling, 2016, Jan-20, Volume: 24, Issue:3

    Topics: Adult; AMP-Activated Protein Kinases; Animals; Carrier Proteins; Female; Fibromyalgia; Humans; Indoles; Inflammasomes; Interleukin-18; Interleukin-1beta; Male; Metformin; Mice; Middle Aged; NLR Family, Pyrin Domain-Containing 3 Protein; Pain; Pain Perception; Phosphorylation; Pyrroles; Sunitinib

2016
Alcohol and high fat induced chronic pancreatitis: TRPV4 antagonist reduces hypersensitivity.
    Neuroscience, 2015, Dec-17, Volume: 311

    Topics: Analgesics; Animals; Diet, High-Fat; Disease Models, Animal; Drug Evaluation, Preclinical; Ethanol; Hot Temperature; Loperamide; Male; Morpholines; Oxidative Stress; Pain; Pain Threshold; Pancreatitis, Chronic; Pyrroles; Random Allocation; Rats, Inbred F344; Receptors, Opioid, mu; Touch; TRPV Cation Channels

2015
Substituted Indazoles as Nav1.7 Blockers for the Treatment of Pain.
    Journal of medicinal chemistry, 2016, Apr-14, Volume: 59, Issue:7

    Topics: Analgesics; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophysiology; Evoked Potentials; Imidazolidines; Indazoles; Iodoacetic Acid; Molecular Structure; NAV1.7 Voltage-Gated Sodium Channel; Osteoarthritis; Pain; Pain Measurement; Pyrroles; Rats; Sodium Channel Blockers; Structure-Activity Relationship

2016
Rational Design and Synthesis of Biologically Active Disubstituted 2(3H) Furanones and Pyrrolone Derivatives as Potent and Safer Non Steroidal Anti-inflammatory Agents.
    Anti-inflammatory & anti-allergy agents in medicinal chemistry, 2016, Volume: 15, Issue:1

    Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Edema; Female; Furans; Male; Mice; Molecular Docking Simulation; Pain; Pyrroles; Rats, Wistar; Stomach Ulcer

2016
Metastatic Renal Cell Carcinoma Presenting as Painful Chewing Successfully Treated with Combined Nivolumab and Sunitinib.
    The Permanente journal, 2016,Summer, Volume: 20, Issue:3

    Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms; Male; Mastication; Neoplasm Metastasis; Nivolumab; Pain; Pyrroles; Sunitinib; Treatment Outcome; United States

2016
Activation of adenylate cyclase-cyclic AMP-protein kinase A signaling by corticotropin-releasing factor within the dorsolateral bed nucleus of the stria terminalis is involved in pain-induced aversion.
    The European journal of neuroscience, 2016, Volume: 44, Issue:11

    Topics: Adenylyl Cyclases; Animals; Carbazoles; Colforsin; Conditioning, Classical; Corticotropin-Releasing Hormone; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Male; Pain; Pyrroles; Rats; Rats, Sprague-Dawley; Septal Nuclei; Signal Transduction

2016
The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of Pain.
    Journal of medicinal chemistry, 2016, 11-23, Volume: 59, Issue:22

    Topics: Dose-Response Relationship, Drug; Drug Discovery; Humans; Models, Molecular; Molecular Structure; Pain; Protein Kinase Inhibitors; Protein Kinases; Pyrimidines; Pyrroles; Quantitative Structure-Activity Relationship

2016
The role of spinal thrombin through protease-activated receptor 1 in hyperalgesia after neural injury.
    Journal of neurosurgery. Spine, 2017, Volume: 26, Issue:4

    Topics: Animals; Antithrombins; Capillary Permeability; Central Nervous System Agents; Cervical Vertebrae; Disease Models, Animal; Fibrin; Hirudins; Hyperalgesia; Injections, Spinal; Male; Pain; Pain Measurement; Peripheral Nervous System Diseases; Pyrroles; Quinazolines; Radiculopathy; Rats, Sprague-Dawley; Receptor, PAR-1; Spinal Cord

2017
PKA and ERK, but not PKC, in the amygdala contribute to pain-related synaptic plasticity and behavior.
    Molecular pain, 2008, Jul-16, Volume: 4

    Topics: Amygdala; Animals; Arthritis; Behavior; Butadienes; Carbazoles; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Indoles; Male; Maleimides; Neuronal Plasticity; Neurons; Nitriles; Pain; Protein Kinase C; Protein Kinase Inhibitors; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Thionucleotides

2008
Addition of receptor tyrosine kinase inhibitor to radiation increases tumour control in an orthotopic murine model of breast cancer metastasis in bone.
    European journal of cancer (Oxford, England : 1990), 2008, Volume: 44, Issue:16

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Breast Neoplasms; Caspases; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Female; Indoles; Mice; Mice, SCID; Microcirculation; Pain; Pyrroles; Radiation-Sensitizing Agents; Sunitinib; Tumor Burden

2008
Ptosis, diplopia and statins: an association?
    European journal of neurology, 2008, Volume: 15, Issue:10

    Topics: Adult; Atorvastatin; Autoantibodies; Autoimmune Diseases of the Nervous System; Azetidines; Blepharoptosis; Diabetes Complications; Diagnostic Errors; Diplopia; Eyelid Diseases; Ezetimibe; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Myasthenia Gravis; Myocardial Infarction; Pain; Pravastatin; Pyrroles; Receptors, Cholinergic; Recurrence; Strabismus

2008
Synthesis, in vitro, and in vivo biological evaluation and molecular docking simulations of chiral alcohol and ether derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents.
    Bioorganic & medicinal chemistry, 2008, Sep-01, Volume: 16, Issue:17

    Topics: Acetic Acid; Alcohols; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Carrageenan; Cells, Cultured; Computer Simulation; Cyclooxygenase 1; Cyclooxygenase 2; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Edema; Enzyme Activation; Enzyme Inhibitors; Ethers; Humans; Isoenzymes; Male; Mice; Models, Chemical; Molecular Structure; Pain; Pain Measurement; Pyrroles; Rats; Rats, Sprague-Dawley; Rats, Wistar; Stereoisomerism; Structure-Activity Relationship

2008
Flare-up: an often unreported phenomenon nevertheless familiar to oncologists prescribing tyrosine kinase inhibitors.
    Acta oncologica (Stockholm, Sweden), 2009, Volume: 48, Issue:4

    Topics: Bone Neoplasms; Carcinoma, Renal Cell; Disease Progression; Drug Administration Schedule; Female; Humans; Indoles; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Middle Aged; Nephrectomy; Pain; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrroles; Sunitinib; Tomography, X-Ray Computed

2009
Sedation and antinociception induced by a new pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivative (LASSBio-873) is modulated by activation of muscarinic receptors.
    Pharmacology, biochemistry, and behavior, 2009, Volume: 94, Issue:1

    Topics: Adrenergic alpha-Antagonists; Analgesics; Analysis of Variance; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; GABA Antagonists; Hot Temperature; Hyperalgesia; Hypnotics and Sedatives; Inflammation; Male; Mice; Motor Activity; Muscarinic Antagonists; Narcotic Antagonists; Pain; Pain Measurement; Pyrazoles; Pyridines; Pyrroles; Receptors, Muscarinic

2009
Apricoxib, a COX-2 inhibitor for the potential treatment of pain and cancer.
    IDrugs : the investigational drugs journal, 2009, Volume: 12, Issue:11

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Cyclooxygenase 2 Inhibitors; Humans; Inflammation; Neoplasms; Pain; Pyrroles; Sulfonamides

2009
Colorectal cancer: response to sunitinib in a heavily pretreated colorectal cancer patient.
    Anti-cancer drugs, 2010, Volume: 21 Suppl 1

    Topics: Activities of Daily Living; Adenocarcinoma; Antineoplastic Agents; Carcinoembryonic Antigen; Colorectal Neoplasms; Compassionate Use Trials; Humans; Indoles; Male; Middle Aged; Pain; Pyrroles; Sunitinib

2010
Role of PKG-L-type calcium channels in the antinociceptive effect of intrathecal sildenafil.
    Journal of veterinary science, 2010, Volume: 11, Issue:2

    Topics: Animals; Calcium Channel Agonists; Calcium Channels, L-Type; Carbazoles; Cyclic GMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Male; Pain; Pain Measurement; Piperazines; Protein Kinase Inhibitors; Purines; Pyrroles; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones

2010
Pain is a salient "stressor" that is mediated by corticotropin-releasing factor-1 receptors.
    Neuropharmacology, 2010, Volume: 59, Issue:3

    Topics: Aniline Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Corticotropin-Releasing Hormone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Hyperalgesia; Indomethacin; Inflammation; Male; Mice; Pain; Pain Threshold; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Spinal Cord Injuries; Stomach Ulcer; Stress, Psychological

2010
Antioxidant, antinociceptive and anti-inflammatory activities of atorvastatin and rosuvastatin in various experimental models.
    Inflammopharmacology, 2010, Volume: 18, Issue:4

    Topics: Alkaline Phosphatase; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Atorvastatin; Edema; Fluorobenzenes; Granuloma; Heptanoic Acids; L-Lactate Dehydrogenase; Liver; Mice; Pain; Pain Measurement; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Rosuvastatin Calcium; Stomach Ulcer; Sulfonamides

2010
Derivatives of pyrrolo[3,4-d]pyridazinone, a new class of analgesic agents.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:10

    Topics: Analgesics; Animals; Crystallography, X-Ray; Male; Mice; Models, Molecular; Pain; Pain Measurement; Pyridazines; Pyrroles; Structure-Activity Relationship

2011
Antinociception induced by atorvastatin in different pain models.
    Pharmacology, biochemistry, and behavior, 2011, Volume: 100, Issue:1

    Topics: Animals; Atorvastatin; Disease Models, Animal; Dose-Response Relationship, Drug; Heptanoic Acids; Hot Temperature; Male; Mice; Pain; Pain Measurement; Pyrroles

2011
Evaluation of anti-inflammatory, anti-nociceptive, and anti-ulcerogenic activities of novel synthesized thiazolyl and pyrrolyl steroids.
    Archiv der Pharmazie, 2011, Volume: 344, Issue:9

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Carrageenan; Disease Models, Animal; Edema; Inflammation; Pain; Pyrroles; Rats; Rats, Sprague-Dawley; Steroids; Stomach Ulcer; Thiazoles; Ulcer

2011
Discovery and hit-to-lead optimization of pyrrolopyrimidines as potent, state-dependent Na(v)1.7 antagonists.
    Bioorganic & medicinal chemistry letters, 2012, Mar-01, Volume: 22, Issue:5

    Topics: Drug Discovery; Humans; Microsomes, Liver; NAV1.7 Voltage-Gated Sodium Channel; Pain; Pyrimidines; Pyrroles; Sodium Channel Blockers; Sodium Channels; Structure-Activity Relationship

2012
Potentiation of the P2X3 ATP receptor by PAR-2 in rat dorsal root ganglia neurons, through protein kinase-dependent mechanisms, contributes to inflammatory pain.
    The European journal of neuroscience, 2012, Volume: 36, Issue:3

    Topics: Adenosine Triphosphate; Animals; Carbazoles; Colforsin; Cyclic AMP-Dependent Protein Kinases; Ganglia, Spinal; Indoles; Inflammation; Male; Maleimides; MAP Kinase Signaling System; Membrane Potentials; Neurons; Pain; Phosphorylation; Protein Kinase C; Protein Transport; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Pyrroles; Rats, Sprague-Dawley; Receptor, PAR-2; Receptors, Purinergic P2X3; Tetradecanoylphorbol Acetate

2012
Discontinuation of statin therapy due to muscular side effects: a survey in real life.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2013, Volume: 23, Issue:9

    Topics: Adult; Aged; Atorvastatin; Dose-Response Relationship, Drug; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Motor Activity; Muscle Cramp; Muscle Weakness; Muscle, Skeletal; Musculoskeletal Diseases; Pain; Pyrimidines; Pyrroles; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Surveys and Questionnaires; Treatment Outcome

2013
Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors.
    Nature biotechnology, 2012, Jul-01, Volume: 30, Issue:7

    Topics: Acetanilides; Caffeic Acids; Cell Culture Techniques; Cell Differentiation; Cell Line; Gene Expression Regulation, Developmental; Humans; Molecular Sequence Data; NAV1.8 Voltage-Gated Sodium Channel; Nociceptors; Pain; Pluripotent Stem Cells; Pyridines; Pyrimidines; Pyrroles; Signal Transduction; Small Molecule Libraries; Tetrodotoxin

2012
A piece of my mind: A pain in the tuches.
    JAMA, 2012, Dec-19, Volume: 308, Issue:23

    Topics: Anticholesteremic Agents; Atorvastatin; Buttocks; Cardiovascular Diseases; Heptanoic Acids; Humans; Medication Adherence; Mortality, Premature; Muscular Diseases; Pain; Physicians; Pyrroles; Sciatica; Self Care

2012
3-Pyrroline containing arylacetamides: a novel series of remarkably selective kappa-agonists.
    Bioorganic & medicinal chemistry letters, 2002, Sep-02, Volume: 12, Issue:17

    Topics: Acetamides; Analgesics, Opioid; Animals; Humans; Injections, Intraperitoneal; Pain; Pyrroles; Radioligand Assay; Rats; Receptors, Opioid, kappa; Structure-Activity Relationship

2002
Summaries for patients. Muscle abnormalities in four patients taking statins to treat unfavorable cholesterol levels.
    Annals of internal medicine, 2002, Oct-01, Volume: 137, Issue:7

    Topics: Aged; Anticholesteremic Agents; Atorvastatin; Biopsy; Creatine Kinase; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Muscular Diseases; Pain; Pyrroles; Simvastatin

2002
Rhabdomyolysis and myalgia associated with anticholesterolemic treatment as potential signs of malignant hyperthermia susceptibility.
    Arthritis and rheumatism, 2003, Apr-15, Volume: 49, Issue:2

    Topics: Atorvastatin; Cholinesterase Inhibitors; Disease Susceptibility; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Malignant Hyperthermia; Middle Aged; Pain; Pyrroles; Rhabdomyolysis

2003
The expression of a high level of morphine antinociceptive tolerance in mice involves both PKC and PKA.
    Brain research, 2003, Sep-19, Volume: 985, Issue:1

    Topics: Analgesics; Animals; Brain; Carbazoles; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Enzyme Inhibitors; Indoles; Injections, Intraventricular; Isoquinolines; Male; Maleimides; Mice; Morphine; Morphine Dependence; Pain; Protein Kinase C; Protein Serine-Threonine Kinases; Pyrroles

2003
Behavioural effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain.
    Neuropharmacology, 2004, Volume: 47, Issue:3

    Topics: Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Excitatory Amino Acid Antagonists; Male; Morphine; Narcotics; Pain; Pain Measurement; Pain Threshold; Peripheral Nervous System Diseases; Pyrroles; Quinoxalines; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Kainic Acid; Tetrahydroisoquinolines; Time Factors

2004
Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
    European journal of pharmacology, 2004, Sep-19, Volume: 499, Issue:1-2

    Topics: Analgesics; Animals; Binding, Competitive; Buprenorphine; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Female; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Ileum; In Vitro Techniques; Macaca mulatta; Male; Mice; Mice, Inbred ICR; Morphinans; Morphine; Muscle Contraction; Pain; Pain Measurement; Pyrroles; Radioligand Assay; Rats; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Sulfur Radioisotopes; Time Factors; Tritium; Vas Deferens

2004
Structure-activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonists.
    Bioorganic & medicinal chemistry letters, 2006, Jul-15, Volume: 16, Issue:14

    Topics: Analgesics; Animals; Benzoates; Biological Availability; Cyclohexanes; Cyclopentanes; Inflammation; Ligands; Pain; Pyrroles; Rats; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Structure-Activity Relationship

2006
PKC and PKA inhibitors reinstate morphine-induced behaviors in morphine tolerant mice.
    Pharmacological research, 2006, Volume: 54, Issue:6

    Topics: Analgesics, Opioid; Animals; Behavior, Animal; Body Temperature; Carbazoles; Cyclic AMP-Dependent Protein Kinases; Drug Implants; Drug Tolerance; Enzyme Inhibitors; Hot Temperature; Hypothermia; Indoles; Injections, Intraventricular; Isoquinolines; Male; Maleimides; Mice; Morphine; Pain; Protein Kinase C; Pyrroles; Reaction Time

2006
1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure-activity relationships of 4- and 5-substituted benzoic acid derivatives.
    Bioorganic & medicinal chemistry letters, 2007, Feb-01, Volume: 17, Issue:3

    Topics: Animals; Benzoates; CHO Cells; Cricetinae; Cricetulus; Inflammation; Pain; Pyrroles; Rats; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Structure-Activity Relationship

2007
1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. Structure-activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives.
    Bioorganic & medicinal chemistry letters, 2007, Feb-15, Volume: 17, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Area Under Curve; Benzoates; Brain; Cell Membrane; CHO Cells; Cricetinae; Cricetulus; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Half-Life; Humans; Indicators and Reagents; Pain; Pain Measurement; Pyrroles; Rats; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Structure-Activity Relationship

2007
Probable statin-induced testicular pain.
    The Annals of pharmacotherapy, 2007, Volume: 41, Issue:1

    Topics: Atorvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pain; Pyrroles; Simvastatin; Testis

2007
Physiogenomic association of statin-related myalgia to serotonin receptors.
    Muscle & nerve, 2007, Volume: 36, Issue:3

    Topics: Aged; Aged, 80 and over; Atorvastatin; Female; Genomics; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Muscular Diseases; Pain; Polymorphism, Single Nucleotide; Pravastatin; Pyrroles; Receptors, Serotonin; Simvastatin

2007
Sunitinib malate and multiple receptor tyrosine kinases inhibitors: are they also novel drugs for chronic and neurophatic pain?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Jul-01, Volume: 25, Issue:19

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Indoles; Neoplasms; Pain; Protein Kinase Inhibitors; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptor, trkA; Signal Transduction; Sunitinib

2007
Letter by Rosenberg and Uretsky regarding article, "Risks associated with statin therapy: a systematic overview of randomized clinical trials".
    Circulation, 2007, Jul-03, Volume: 116, Issue:1

    Topics: Atorvastatin; Biomarkers; Creatine Kinase, MM Form; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases; Pain; Pyrroles; Randomized Controlled Trials as Topic; Rhabdomyolysis

2007
Preclinical pharmacology profile of CS-706, a novel cyclooxygenase-2 selective inhibitor, with potent antinociceptive and anti-inflammatory effects.
    European journal of pharmacology, 2008, Jan-06, Volume: 578, Issue:1

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Arthritis; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Inflammation; Inhibitory Concentration 50; Pain; Pain Measurement; Pyrroles; Rats; Rats, Inbred Lew; Rats, Wistar; Sulfonamides

2008
Discovery of orally efficacious tetracyclic metabotropic glutamate receptor 1 (mGluR1) antagonists for the treatment of chronic pain.
    Journal of medicinal chemistry, 2007, Nov-15, Volume: 50, Issue:23

    Topics: Analgesics; Animals; Area Under Curve; Chronic Disease; Heterocyclic Compounds, 4 or More Rings; Humans; Indazoles; Morpholines; Pain; Peripheral Nervous System Diseases; Pyridines; Pyrroles; Rats; Receptors, Metabotropic Glutamate; Structure-Activity Relationship

2007
LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    European journal of pharmacology, 2008, Apr-28, Volume: 584, Issue:2-3

    Topics: Acetic Acid; Analgesics, Opioid; Animals; Behavior, Animal; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Hot Temperature; Humans; Male; Mice; Motor Activity; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Pain; Pain Measurement; Pain Threshold; Protein Binding; Pyrroles; Rats; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Time Factors; Transfection

2008
Zomepirac-induced renal failure.
    Archives of internal medicine, 1983, Volume: 143, Issue:6

    Topics: Acute Kidney Injury; Adult; Aged; Arthritis; Back Pain; Body Weight; Coronary Artery Bypass; Creatinine; Female; Headache; Humans; Male; Pain; Postoperative Complications; Pyrroles; Time Factors; Tolmetin

1983
Central effects of zomepirac on pain evoked by intraneural stimulation in man.
    Journal of clinical pharmacology, 1984, Volume: 24, Issue:10

    Topics: Adolescent; Adult; Double-Blind Method; Electric Stimulation; Humans; Neurons; Pain; Pyrroles; Tolmetin

1984
Site of analgesic action of zomepirac sodium, a potent non-narcotic analgesic in experimental animals.
    Japanese journal of pharmacology, 1983, Volume: 33, Issue:4

    Topics: Alprostadil; Analgesics; Animals; Ascitic Fluid; Bradykinin; Dogs; Hypertension; Injections, Intraventricular; Male; Naloxone; Pain; Prostaglandins E; Pyrroles; Rats; Rats, Inbred Strains; Tolmetin

1983
A zomepirac reaction mimicking ectopic pregnancy.
    Drug intelligence & clinical pharmacy, 1984, Volume: 18, Issue:6

    Topics: Adult; Diagnosis, Differential; Drug Hypersensitivity; Female; Humans; Hypotension; Pain; Pregnancy; Pregnancy, Ectopic; Pyrroles; Rupture, Spontaneous; Tolmetin

1984
Nonoliguric renal failure associated with zomepirac.
    JAMA, 1983, Apr-01, Volume: 249, Issue:13

    Topics: Acute Kidney Injury; Analgesics; Humans; Male; Middle Aged; Oliguria; Pain; Pyrroles; Tolmetin

1983
Zomepirac-induced serum sickness. A report of two cases.
    JAMA, 1983, May-27, Volume: 249, Issue:20

    Topics: Adult; Analgesics; Drug Hypersensitivity; Humans; Male; Middle Aged; Pain; Pyrroles; Serum Sickness; Tolmetin

1983
Renal failure and tubular dysfunction due to zomepirac therapy.
    JAMA, 1983, Jan-21, Volume: 249, Issue:3

    Topics: Acidosis, Renal Tubular; Aged; Analgesics; Female; Humans; Joint Diseases; Kidney Failure, Chronic; Middle Aged; Pain; Pyrroles; Tolmetin

1983
Zomepirac sodium. Learn about this potent new non-narcotic analgesic.
    Nursing, 1981, Volume: 11, Issue:6

    Topics: Adult; Analgesics; Child; Female; Humans; Male; Pain; Pyrroles; Tolmetin

1981
[Zomax--progress in analgesia. A new, non-narcotic analgesic].
    Swiss dent, 1981, Volume: 2, Issue:9

    Topics: Analgesics; Humans; Kinetics; Pain; Pyrroles; Tolmetin

1981
[Preliminary pharmacological studies of a new anti-inflammatory agent: 4'-acetamidophenyl-2-(5'-p-toluyl-1'-methylpyrrole)acetate].
    Bollettino chimico farmaceutico, 1982, Volume: 121, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Evaluation, Preclinical; Edema; Male; Pain; Pyrroles; Rats; Rats, Inbred Strains; Tolmetin

1982
The analgesic and anti-inflammatory profile of (+/-)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2a]pyrrole-1-carboxylic acid (RS-37619).
    Agents and actions, 1982, Volume: 12, Issue:5-6

    Topics: Adrenal Cortex Hormones; Analgesics; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cardiovascular System; Central Nervous System; Digestive System; Edema; Granuloma; Ketorolac; Mice; Mice, Inbred Strains; Pain; Pyrroles; Rats; Rats, Inbred Strains; Tolmetin

1982
Nonsteroidal anti-inflammatory: zomepirac sodium.
    Geriatrics, 1982, Volume: 37, Issue:2

    Topics: Aged; Anti-Inflammatory Agents; Humans; Pain; Pyrroles; Tolmetin

1982
Anaphylactic shock, acute renal failure, and disseminated intravascular coagulation. Suspected complications of zomepirac.
    JAMA, 1982, Feb-26, Volume: 247, Issue:8

    Topics: Acute Kidney Injury; Aged; Anaphylaxis; Disseminated Intravascular Coagulation; Humans; Male; Pain; Pyrroles; Tolmetin

1982
[A drug fights pain on two levels].
    Medizinische Klinik (Praxis-Ausg.), 1982, Jun-18, Volume: 77, Issue:13

    Topics: Analgesics; Humans; Nociceptors; Pain; Pyrroles; Tolmetin

1982
Site of analgesic action of a non-steroidal, anti-inflammatory drug, tolmetin sodium, in rats.
    British journal of pharmacology, 1981, Volume: 73, Issue:3

    Topics: Administration, Oral; Animals; Ascitic Fluid; Injections, Intraperitoneal; Injections, Intravenous; Male; Pain; Peritoneum; Pyrroles; Rats; Tolmetin

1981
Tolmetin-induced aseptic meningitis.
    JAMA, 1981, Jan-02, Volume: 245, Issue:1

    Topics: Adult; Female; Fever; Humans; Ibuprofen; Knee; Lupus Erythematosus, Systemic; Meningitis; Meningitis, Aseptic; Pain; Pyrroles; Tolmetin

1981
Subgroups among mu-opioid receptor agonists distinguished by ATP-sensitive K+ channel-acting drugs.
    British journal of pharmacology, 1995, Volume: 114, Issue:6

    Topics: 4-Aminopyridine; Adenosine Triphosphate; Animals; Baclofen; Benzopyrans; Cromakalim; Female; Mice; Neurons; Pain; Potassium Channels; Pyrroles; Receptors, Opioid, mu; Sulfonylurea Compounds; Tetraethylammonium; Tetraethylammonium Compounds

1995
Further evidence that substance P is a mediator of both neurogenic inflammation and pain: two phenomena inhibited either by postsynaptic blockade of NK1 receptors or by presynaptic action of opioid receptor agonists.
    Regulatory peptides, 1993, Jul-02, Volume: 46, Issue:1-2

    Topics: Analgesics; Animals; Anticonvulsants; Electric Stimulation; Formaldehyde; Indoles; Inflammation; Isoindoles; Male; Mice; Mice, Inbred Strains; Morphine; Pain; Peripheral Nerves; Pyrroles; Rats; Rats, Sprague-Dawley; Substance P; Thiophenes

1993
Effect of fedotozine on the cardiovascular pain reflex induced by distension of the irritated colon in the anesthetized rat.
    European journal of pharmacology, 1994, Dec-27, Volume: 271, Issue:2-3

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Acetates; Acetic Acid; Amino Acid Sequence; Anesthesia; Animals; Benzyl Compounds; Blood Pressure; Colon; Dose-Response Relationship, Drug; Male; Molecular Sequence Data; Pain; Propylamines; Pyrroles; Pyrrolidines; Rats; Rats, Sprague-Dawley; Reflex; Thiophenes

1994
Cromakalim differentially enhances antinociception induced by agonists of alpha(2)adrenoceptors, gamma-aminobutyric acid(B), mu and kappa opioid receptors.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 276, Issue:3

    Topics: Animals; Baclofen; Benzopyrans; Cromakalim; Dose-Response Relationship, Drug; Female; Mice; Mice, Inbred Strains; Morphine; Nociceptors; Pain; Pyrroles; Receptors, Opioid, kappa; Receptors, Opioid, mu; Vasodilator Agents

1996
Reversal by kappa-agonists of peritoneal irritation-induced ileus and visceral pain in rats.
    Life sciences, 1997, Volume: 60, Issue:9

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Acetic Acid; Analgesics; Animals; Benzofurans; Benzomorphans; Cyclazocine; Fentanyl; Gastric Emptying; Intestinal Pseudo-Obstruction; Male; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Peritoneum; Pyrroles; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Thiophenes

1997
A dual effect of 5-HT1B receptor stimulation on nociceptive dorsal horn neurones in rats.
    European journal of pharmacology, 1997, Sep-24, Volume: 335, Issue:2-3

    Topics: Action Potentials; Animals; Drug Interactions; Electric Stimulation; Female; Neurons; Pain; Pindolol; Piperazines; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Serotonin Receptor Agonists; Spinal Cord; Synaptic Transmission

1997
Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH.
    Proceedings of the National Academy of Sciences of the United States of America, 1999, Jul-06, Volume: 96, Issue:14

    Topics: Animals; Avoidance Learning; Cerebral Ventricles; Conditioning, Operant; Corticotropin-Releasing Hormone; Crosses, Genetic; Electroshock; Fear; Female; Gene Expression Regulation; Injections, Intraventricular; Learning; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Motor Activity; Pain; Pyrimidines; Pyrroles; Receptors, Corticotropin-Releasing Hormone; Reinforcement, Psychology; Stress, Psychological; Transcription, Genetic; Urocortins

1999
Possible involvement of spinal protein kinase C in thermal allodynia and hyperalgesia in diabetic mice.
    European journal of pharmacology, 1999, May-21, Volume: 372, Issue:3

    Topics: Analysis of Variance; Animals; Capsaicin; Carbazoles; Carcinogens; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus; Enzyme Inhibitors; Hot Temperature; Hyperalgesia; Indoles; Male; Mice; Mice, Inbred ICR; Naphthalenes; Pain; Pain Measurement; Phorbol 12,13-Dibutyrate; Protein Kinase C; Pyrroles; Spinal Cord

1999
Synthesis of some N-substituted 3,4-pyrroledicarboximides as potential CNS depressive agents.
    Die Pharmazie, 2000, Volume: 55, Issue:1

    Topics: Amphetamine; Analgesics, Non-Narcotic; Animals; Anticonvulsants; Behavior, Animal; Blood Pressure; Central Nervous System Depressants; Central Nervous System Stimulants; Female; Lethal Dose 50; Magnetic Resonance Spectroscopy; Male; Mice; Motor Activity; Pain; Psychomotor Performance; Pyrroles; Rats; Rats, Wistar; Spectrophotometry, Infrared

2000
Role of the phosphatidylinositol-specific phospholipase C pathway in delta-opioid receptor-mediated antinociception in the mouse spinal cord.
    Neuroscience, 2000, Volume: 99, Issue:2

    Topics: Analgesics; Animals; Carbazoles; Cyclic AMP-Dependent Protein Kinases; Estrenes; Indoles; Inositol 1,4,5-Trisphosphate; Male; Mice; Mice, Inbred ICR; Naphthalenes; Oligopeptides; Pain; Pain Measurement; Phosphatidylinositols; Protein Kinase C; Pyrroles; Pyrrolidinones; Receptors, Opioid, delta; Signal Transduction; Spinal Cord; Type C Phospholipases

2000
Statin induced myopathy does not show up in MIBI scintigraphy.
    Nuclear medicine communications, 2001, Volume: 22, Issue:5

    Topics: Adult; Anticholesteremic Agents; Atorvastatin; Breast Neoplasms; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Indoles; Lovastatin; Male; Middle Aged; Muscle, Skeletal; Muscular Diseases; Pain; Pravastatin; Pyridines; Pyrroles; Radionuclide Imaging; Radiopharmaceuticals; Simvastatin; Technetium Tc 99m Sestamibi

2001
Effects of 5-HT2 and 5-HT3 receptors on the modulation of nociceptive transmission in rat spinal cord according to the formalin test.
    European journal of pharmacology, 2001, Jul-13, Volume: 424, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Dose-Response Relationship, Drug; Formaldehyde; Injections, Spinal; Male; Nociceptors; Pain; Pain Measurement; Pyridines; Pyrroles; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Spinal Cord; Synaptic Transmission; Tropanes

2001
Atorvastatin-induced diaphragmatic muscle impairment.
    The Annals of pharmacotherapy, 2001, Volume: 35, Issue:10

    Topics: Asthenia; Atorvastatin; Diaphragm; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscles; Pain; Pyrroles

2001
GV196771A, an NMDA receptor/glycine site antagonist, attenuates mechanical allodynia in neuropathic rats and reduces tolerance induced by morphine in mice.
    European journal of pharmacology, 2001, Nov-02, Volume: 430, Issue:2-3

    Topics: Animals; Behavior, Animal; Binding Sites; Constriction, Pathologic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Excitatory Amino Acid Antagonists; Glycine; Indoles; Ligation; Male; Mice; Morphine; Narcotics; Neuralgia; Pain; Pain Measurement; Pain Threshold; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sciatic Nerve; Stress, Mechanical

2001
Clinical analgesic assay of oral zomepirac and intramuscular morphine.
    NIDA research monograph, 1979, Volume: 27

    Topics: Administration, Oral; Affect; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Humans; Morphine; Pain; Pain, Postoperative; Pyrroles; Research Design; Tolmetin

1979
Involvement of a peripheral component in the antinociceptive effects of opioids in a model of tonic pain.
    NIDA research monograph, 1990, Volume: 105

    Topics: Animals; Anticonvulsants; Disease Models, Animal; Male; Morphine; Narcotics; Pain; Peripheral Nerves; Pyrroles; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Thiophenes

1990
Standardization of the rat paw formalin test for the evaluation of analgesics.
    Psychopharmacology, 1991, Volume: 104, Issue:1

    Topics: Analgesics; Animals; Aspirin; Behavior, Animal; Decerebrate State; Foot; Formaldehyde; Male; Morphine; Pain; Pyrroles; Rats; Rats, Inbred Strains; Reference Standards; Thiophenes

1991
Research on psychotropic agents. III. Antidepressant activity and neuropsychobehavioural effects of new 5H-Pyrrolo[1,2-b][1,2,5]benzotriazepine derivatives.
    Farmaco (Societa chimica italiana : 1989), 1990, Volume: 45, Issue:1

    Topics: Animals; Anticonvulsants; Antidepressive Agents; Benzazepines; Chemical Phenomena; Chemistry; Exploratory Behavior; Female; Male; Mice; Motor Activity; Muscle Relaxants, Central; Pain; Postural Balance; Psychotropic Drugs; Pyrroles; Sensory Thresholds

1990
Comparison of PD 117302, a kappa agonist, and morphine on colonic transit and formalin-induced pain in rats.
    Proceedings of the Western Pharmacology Society, 1989, Volume: 32

    Topics: Animals; Colon; Dose-Response Relationship, Drug; Formaldehyde; Gastrointestinal Transit; Male; Morphine; Pain; Pyrroles; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Thiophenes

1989
Pharmacological profile of PD 117302, a selective kappa-opioid agonist.
    British journal of pharmacology, 1987, Volume: 92, Issue:4

    Topics: Analgesics; Animals; Depression, Chemical; Diuretics; Gastrointestinal Motility; Injections, Intravenous; Male; Mice; Pain; Pyrroles; Rats; Rats, Inbred Strains; Reaction Time; Receptors, Opioid; Receptors, Opioid, kappa; Respiration; Substance-Related Disorders; Thiophenes

1987
Synthesis and antiinflammatory and analgesic activity of 5-aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acids and related compounds.
    Journal of medicinal chemistry, 1985, Volume: 28, Issue:8

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Edema; Male; Mice; Pain; Pyrroles; Rats; Structure-Activity Relationship

1985
Clinical evaluation of tolmetin.
    Current medical research and opinion, 1974, Volume: 2, Issue:6

    Topics: Administration, Oral; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Benzoates; Female; Humans; Male; Middle Aged; Pain; Pyrroles; Radioisotopes; Statistics as Topic; Technetium

1974
Exertion of delta-aminolevulinic acid in hereditary tyrosinemia.
    Clinica chimica acta; international journal of clinical chemistry, 1969, Volume: 23, Issue:2

    Topics: Abdomen; Adolescent; Amino Acid Metabolism, Inborn Errors; Amino Acids; Child; Creatinine; Feces; Female; Humans; Leg; Levulinic Acids; Male; Pain; Paresis; Phenylalanine; Porphyrins; Pyrroles; Tritium; Tyrosine

1969